Human trials of British coronavirus vaccine to widen to 10,000

Oxford University and AstraZeneca plan to recruit around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine which on Thursday received U.S. backing worth up to $1.2 billion.